Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 10Withdrawn 3Terminated 3Recruiting 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 87INDUSTRY 37NIH 16NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 37Gastrointestinal 35Thoracic 29Lymphoid 26Genitourinary 24Breast 24CNS 23Sarcoma 20Other hematologic neoplasm 15Dermatologic 15Head & Neck 14Plasma cell 9Endocrine 3Other solid neoplasm 2Other neoplasm 2Myeloid 2Tumor-Agnostic 1Other 1

Conditions

Somatostatinoma 1Pituitary Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Carcinoma, Islet Cell 1Adrenocortical Carcinoma 1

Interventions

Suramin 1Hydrocortisone 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × Endocrine × Clear all
NCT02031536 2023-06-29

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Eastern Cooperative Oncology Group

Phase 2 Terminated
2 enrolled 8 charts
Endocrine

Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT02743442 2021-03-29

ROBOPHYSE

Fondation Ophtalmologique Adolphe de Rothschild

Phase NA Terminated
8 enrolled 8 charts
Endocrine

Pituitary Neoplasms

NCT00002921 2012-10-05

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

SWOG Cancer Research Network

Phase 2 Terminated
13 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡